Lockheed Martin Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.31M | Sell |
77,480
-8,440
| -10% | -$458K | 0.13% | 91 |
|
|
2026
Q1 | $5.39M | Buy |
85,920
+31,370
| +58% | +$2.51M | 0.2% | 76 |
|
|
2025
Q4 | $5.2M | Buy |
54,550
+5,840
| +12% | +$573K | 0.17% | 73 |
|
|
2025
Q3 | $4.76M | Sell |
48,710
-1,800
| -4% | -$186K | 0.18% | 79 |
|
|
2025
Q2 | $5.43M | Sell |
50,510
-3,430
| -6% | -$347K | 0.2% | 77 |
|
|
2025
Q1 | $5.44M | Sell |
53,940
-1,280
| -2% | -$129K | 0.22% | 74 |
|
|
2024
Q4 | $4.93M | Sell |
55,220
-740
| -1% | -$65.1K | 0.2% | 70 |
|
|
2024
Q3 | $4.69M | Sell |
55,960
-66,520
| -54% | -$5.24M | 0.22% | 69 |
|
|
2024
Q2 | $9.43M | Sell |
122,480
-4,410
| -3% | -$323K | 0.55% | 44 |
|
|
2024
Q1 | $7.18M | Sell |
126,890
-108,542
| -46% | -$6.98M | 0.52% | 43 |
|
|
2023
Q4 | $11.7M | Sell |
235,432
-35,900
| -13% | -$1.92M | 0.84% | 33 |
|
|
2023
Q3 | $12.8M | Sell |
271,332
-45,630
| -14% | -$2.39M | 0.98% | 26 |
|
|
2023
Q2 | $17.1M | Sell |
316,962
-3,000
| -0.9% | -$157K | 0.98% | 27 |
|
|
2023
Q1 | $16M | Buy |
319,962
+56,190
| +21% | +$2.65M | 0.91% | 24 |
|
|
2022
Q4 | $12.2M | Buy |
263,772
+55,670
| +27% | +$2.41M | 0.81% | 38 |
|
|
2022
Q3 | $8.06M | Hold |
208,102
| – | – | 0.65% | 49 |
|
|
2022
Q2 | $7.75M | Sell |
208,102
-13,780
| -6% | -$561K | 0.53% | 49 |
|
|
2022
Q1 | $9.83M | Buy |
221,882
+19,610
| +10% | +$850K | 0.54% | 51 |
|
|
2021
Q4 | $8.59M | Hold |
202,272
| – | – | 0.46% | 53 |
|
|
2021
Q3 | $8.78M | Sell |
202,272
-98,480
| -33% | -$4.36M | 0.48% | 42 |
|
|
2021
Q2 | $12.9M | Sell |
300,752
-88,030
| -23% | -$3.7M | 0.67% | 36 |
|
|
2021
Q1 | $15M | Buy |
388,782
+121,920
| +46% | +$4.61M | 0.77% | 37 |
|
|
2020
Q4 | $9.59M | Sell |
266,862
-143,000
| -35% | -$5.15M | 0.5% | 50 |
|
|
2020
Q3 | $15.7M | Sell |
409,862
-45,190
| -10% | -$1.74M | 0.97% | 20 |
|
|
2020
Q2 | $16M | Hold |
455,052
| – | – | 1.06% | 18 |
|
|
2020
Q1 | $14.8M | Buy |
455,052
+64,500
| +17% | +$2.52M | 1.01% | 18 |
|
|
2019
Q4 | $17.7M | Buy |
390,552
+50,312
| +15% | +$2.11M | 0.93% | 22 |
|
|
2019
Q3 | $13.8M | Sell |
340,240
-9,560
| -3% | -$405K | 0.88% | 18 |
|
|
2019
Q2 | $15M | Buy |
349,800
+159,100
| +83% | +$6.12M | 0.68% | 35 |
|
|
2019
Q1 | $7.32M | Buy |
190,700
+128,900
| +209% | +$4.92M | 0.33% | 45 |
|
|
2018
Q4 | $2.18M | Buy |
+61,800
| New | +$2.24M | 0.1% | 50 |
|
|
2017
Q3 | – | Sell |
-137,000
| Closed | -$3.8M | – | 133 |
|
|
2017
Q2 | $3.8M | Buy |
+137,000
| New | +$3.64M | 0.21% | 62 |
|
Other funds holding BSX
Lockheed Martin Investment Management's BSX Position: Q2 2026 in Review
Lockheed Martin Investment Management reduced its Boston Scientific (BSX) stake by 9.8% in Q2 2026, selling an estimated $458K and leaving 77,480 shares worth $3.31M. The position accounts for 0.13% of the portfolio, ranked #91.
Lockheed Martin Investment Management first reported a position in BSX in Q2 2017 and has held it in 32 quarters since. The position peaked at $17.7M in Q4 2019. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Lockheed Martin Investment Management held 77,480 shares of Boston Scientific worth $3.31M as of Q2 2026.
- Lockheed Martin Investment Management sold 8,440 Boston Scientific shares in Q2 2026, an estimated $458K.
- Boston Scientific made up 0.13% of Lockheed Martin Investment Management's portfolio in Q2 2026, its #91 holding.
- Lockheed Martin Investment Management first reported a position in Boston Scientific in Q2 2017 and has held it in 32 quarters since.
- Lockheed Martin Investment Management's Boston Scientific position peaked at $17.7M in Q4 2019.
- 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Lockheed Martin Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.